Cargando…

Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Zhao, Xiangyu, Wu, Haotian, Cheng, Yifei, Xu, Zhengli, Chen, Yuhong, Chang, Yingjun, Wang, Yu, Zhang, Xiaohui, Xu, Lanping, Huang, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431388/
https://www.ncbi.nlm.nih.gov/pubmed/37462037
http://dx.doi.org/10.1097/CM9.0000000000002764
_version_ 1785091188945059840
author Zhao, Xiangyu
Wu, Haotian
Cheng, Yifei
Xu, Zhengli
Chen, Yuhong
Chang, Yingjun
Wang, Yu
Zhang, Xiaohui
Xu, Lanping
Huang, Xiaojun
author_facet Zhao, Xiangyu
Wu, Haotian
Cheng, Yifei
Xu, Zhengli
Chen, Yuhong
Chang, Yingjun
Wang, Yu
Zhang, Xiaohui
Xu, Lanping
Huang, Xiaojun
author_sort Zhao, Xiangyu
collection PubMed
description
format Online
Article
Text
id pubmed-10431388
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104313882023-08-20 Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia Zhao, Xiangyu Wu, Haotian Cheng, Yifei Xu, Zhengli Chen, Yuhong Chang, Yingjun Wang, Yu Zhang, Xiaohui Xu, Lanping Huang, Xiaojun Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-07-18 2023-08-20 /pmc/articles/PMC10431388/ /pubmed/37462037 http://dx.doi.org/10.1097/CM9.0000000000002764 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Zhao, Xiangyu
Wu, Haotian
Cheng, Yifei
Xu, Zhengli
Chen, Yuhong
Chang, Yingjun
Wang, Yu
Zhang, Xiaohui
Xu, Lanping
Huang, Xiaojun
Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
title Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
title_full Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
title_fullStr Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
title_full_unstemmed Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
title_short Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
title_sort bridging chimeric antigen receptor t-cell before transplantation improves prognosis of relapsed/refractory b-cell acute lymphoblastic leukemia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431388/
https://www.ncbi.nlm.nih.gov/pubmed/37462037
http://dx.doi.org/10.1097/CM9.0000000000002764
work_keys_str_mv AT zhaoxiangyu bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT wuhaotian bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT chengyifei bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT xuzhengli bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT chenyuhong bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT changyingjun bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT wangyu bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT zhangxiaohui bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT xulanping bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia
AT huangxiaojun bridgingchimericantigenreceptortcellbeforetransplantationimprovesprognosisofrelapsedrefractorybcellacutelymphoblasticleukemia